349 related articles for article (PubMed ID: 9067122)
1. Tamoxifen and secondary tumours. An update.
Wilking N; Isaksson E; von Schoultz E
Drug Saf; 1997 Feb; 16(2):104-17. PubMed ID: 9067122
[TBL] [Abstract][Full Text] [Related]
2. Re: second cancers after adjuvant tamoxifen therapy for breast cancer.
Rutqvist LE
J Natl Cancer Inst; 1996 Oct; 88(20):1497-9; author reply, 1497-9. PubMed ID: 8841030
[No Abstract] [Full Text] [Related]
3. Tamoxifen and the endometrium.
Barakat RR
Cancer Treat Res; 1998; 94():195-207. PubMed ID: 9587689
[No Abstract] [Full Text] [Related]
4. The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review.
Law CH; Tandan VR
Can J Surg; 1999 Jun; 42(3):211-4. PubMed ID: 10372018
[TBL] [Abstract][Full Text] [Related]
5. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogen therapy: uncertainties and risk assessment.
Smith LL; White IN
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
[TBL] [Abstract][Full Text] [Related]
7. Gynaecological aspects of tamoxifen treatment in breast cancer patients.
Obwegeser R; Auerbach L; Kubista E
Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881
[No Abstract] [Full Text] [Related]
8. Iatrogenic endometrial megapolyps in women with breast carcinoma.
Berezowsky J; Chalvardjian A; Murray D
Obstet Gynecol; 1994 Oct; 84(4 Pt 2):727-30. PubMed ID: 9205466
[TBL] [Abstract][Full Text] [Related]
9. The tamoxifen dilemma.
White IN
Carcinogenesis; 1999 Jul; 20(7):1153-60. PubMed ID: 10383884
[TBL] [Abstract][Full Text] [Related]
10. The duration of adjuvant tamoxifen therapy.
Bilimoria MM; Jordan VC
Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
[No Abstract] [Full Text] [Related]
11. Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary note.
Kuwashima Y; Kurosumi M; Kobayashi Y; Tanuma J; Suemasu K; Higashi Y; Kasamatsu T; Shiromizu K; Matsuzawa M; Kishi K
Anticancer Res; 1996; 16(5A):2993-6. PubMed ID: 8917418
[TBL] [Abstract][Full Text] [Related]
12. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients.
Hemminki K; Rajaniemi H; Lindahl B; Moberger B
Cancer Res; 1996 Oct; 56(19):4374-7. PubMed ID: 8813128
[TBL] [Abstract][Full Text] [Related]
14. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
Jagavkar RS; Shakespeare TP; Stevens MJ
Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
[No Abstract] [Full Text] [Related]
15. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
[TBL] [Abstract][Full Text] [Related]
16. Second cancers after adjuvant tamoxifen therapy for breast cancer.
Curtis RE; Boice JD; Shriner DA; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1996 Jun; 88(12):832-4. PubMed ID: 8637050
[No Abstract] [Full Text] [Related]
17. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.
Rutqvist LE; Johansson H; Signomklao T; Johansson U; Fornander T; Wilking N
J Natl Cancer Inst; 1995 May; 87(9):645-51. PubMed ID: 7752269
[TBL] [Abstract][Full Text] [Related]
18. Scientific review of tamoxifen. Overview from a medical oncologist.
Carlson RW
Semin Oncol; 1997 Feb; 24(1 Suppl 1):S1-151-S1-7. PubMed ID: 9045312
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors.
Cobleigh MA
Cancer Treat Res; 1998; 94():209-30. PubMed ID: 9587690
[No Abstract] [Full Text] [Related]
20. Tamoxifen and the uterus.
Vergote I; Neven P; Vanderick G; van Dam P; Van Belle Y; De Sutter Ph; De Prins F; De Muylder X; Claerhout J; Campo R; Albertyn G
Eur J Cancer; 1998 Aug; 34 Suppl 4():S1-3. PubMed ID: 9917139
[No Abstract] [Full Text] [Related]
[Next] [New Search]